Medical News

RSS

Research article reports association of chronic upper GI symptoms with diabetes

There are several papers which report the association of GI symptoms with diabetes. Epidemiological data regarding the association of GI symptoms with diabetes are, however, inconsistent, and the reported frequency of upper and lower GI symptoms varies among different ethnic groups/populations.

13 Apr 2010

Researchers evaluate new treatment for coronary heart disease

Some patients with heart muscles seriously affected by coronary heart disease may soon be able to benefit from an innovative treatment.

13 Apr 2010

Cytomedix to acquire Sorin's Angel blood separation system and activAT Autologous Thrombin Processing Kit

Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the closing of an agreement with Sorin Group, a global leader in the treatment of cardiovascular diseases, to acquire the Angel® Whole Blood Separation System and activAT® Autologous Thrombin Processing Kit for $7 million in cash, to be paid in installments over the next two and one-half years.

13 Apr 2010

Exercise tips for summer season

The summer is a great season for getting in shape. Whether by playing a sport, an aerobic exercise routine, or just returning to that familiar running path -- this is the time for activity.

13 Apr 2010

AIM Health Group's net income increased to $1.3M from a loss of $2.9M in 2008

AIM Health Group Inc., a fully integrated health care company, announced today that its net income for the year ended December 31, 2009 ("Fiscal 2009") increased to $1.3 million from a loss of $2.9 million in 2008. At the same time EBITDA increased to $3.0 million from negative $0.3 million on a year-over-year basis.

13 Apr 2010

California hospital error data reveals fines, gaps in reporting

"California regulators have fined hospitals just over $1 million for failing to report incidents such as leaving a foreign object in a patient after a surgery or operating on the wrong person, according to data released to California Watch by the California Department of Public Health."

13 Apr 2010

COAG to work out deal on proposed health reforms

NSW Premier Kristina Keneally was hopeful that Prime Minister Kevin Rudd’s health reforms proposed would be beneficial to the states despite the major opposition that it has seen. Ms Keneally chaired a teleconference on Monday night with first ministers after Mr Rudd released the full details of his health reforms.

12 Apr 2010

Elastomers speed regulatory compliance of speech therapy devices, enhance toughness

A supplier of tools to aid in speech therapy has switched from conventional thermoplastic elastomers to Medalist® medical elastomers from Teknor Apex Company, citing advantages in compound selection, blending, molding, and resistance to chewing and other rugged treatment.

12 Apr 2010

Overcoming resistance - new options for the treatment of ovarian cancer

Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism with the help of a monoclonal antibody. The results of this project, which was funded by the Austrian Science Fund FWF, have just been published. The project also succeeded in establishing a hitherto unknown connection between so-called "natural killer cells" and the regulated death of cancer cells.

12 Apr 2010

RXi Pharmaceuticals, Mirna Therapeutics form microRNA research collaboration

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.

12 Apr 2010

COBRA subsidy extension Senate vote expected today

Congressional Quarterly: A 65 percent subsidy that helped laid-off Americans pay for their COBRA health insurance premiums expired March 31, just before the Congressional recess. Now, one of the first orders of business is voting on legislation that would extend that subsidy. "With 15 million Americans unemployed, some advocates for the jobless say Congress should not only be extending the COBRA subsidies but expanding them — either with more-generous subsidies or by changing the law to make more people eligible."

12 Apr 2010

Mylan Pharmaceuticals' ANDA for generic Wellbutrin SR receives FDA final approval

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP, (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline's antidepressant Wellbutrin SR®.

12 Apr 2010

More states coping with primary care shortage

In a major feature, The Tennessean reports that the "nation is short 16,663 primary care doctors, and by 2025 that number will reach nearly 140,000, according to the American Academy of Family Physicians."

12 Apr 2010

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.

12 Apr 2010

Diasorin migrates to Orange Business Services' Business VPN solution

Diasorin S.p.A., an international player in the market of in vitro diagnostics based in Saluggia (Vercelli, Italy), has migrated to Business VPN, a fully-managed, secure, global IP infrastructure from Orange Business Services connecting 12 locations in Europe, the Americas and Asia.

12 Apr 2010

Drinking during adolescence increases risk of benign breast disease in young women

Girls and young women who drink alcohol increase their risk of benign (noncancerous) breast disease, says a study by researchers at Washington University School of Medicine in St. Louis and Harvard University. Benign breast disease increases the risk for developing breast cancer.

12 Apr 2010

With health debate resolved, investors see continued health sector growth

After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."

12 Apr 2010

Hospira's proposed merger and loan agreements better than MPI's, says Javelin Pharmaceuticals

Javelin Pharmaceuticals, Inc. announced today that it had received a binding offer from Hospira, Inc. and its wholly-owned subsidiary, Discus Acquisition Corporation ("Discus"), to enter into a merger agreement, a loan and security agreement and intellectual property security agreements whereby Discus will, subject to certain conditions, commence an all cash tender offer to acquire all of the outstanding shares of Javelin at a per share price of $2.20.

12 Apr 2010

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

12 Apr 2010

Biomedical Systems selects Global 360's Process360 BPM suite for improving report, image communication

Global 360, a leading provider of Process and Document Management solutions, today announced that Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, has chosen Global 360 to improve how critical reports and images are communicated and reported to its customers. In the process, the company will also save thousands on courier costs, satisfy a "going green" initiative, and mitigate risk, helping satisfy auditors and regulators.

12 Apr 2010